Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1983 2
1984 4
1986 9
1987 5
1988 3
1989 5
1990 4
1991 8
1992 8
1993 4
1994 2
1995 11
1996 7
1997 3
1998 4
1999 4
2000 4
2001 4
2002 5
2003 7
2004 5
2005 13
2006 10
2007 10
2008 8
2009 12
2010 20
2011 12
2012 12
2013 14
2014 11
2015 12
2016 9
2017 15
2018 13
2019 15
2020 16
2021 5
2022 5
2023 8
2024 6
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

311 results

Results by year

Filters applied: . Clear all
Page 1
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults.
Kallás EG, Cintra MAT, Moreira JA, Patiño EG, Braga PE, Tenório JCV, Infante V, Palacios R, de Lacerda MVG, Batista Pereira D, da Fonseca AJ, Gurgel RQ, Coelho IC, Fontes CJF, Marques ETA, Romero GAS, Teixeira MM, Siqueira AM, Barral AMP, Boaventura VS, Ramos F, Elias Júnior E, Cassio de Moraes J, Covas DT, Kalil J, Precioso AR, Whitehead SS, Esteves-Jaramillo A, Shekar T, Lee JJ, Macey J, Kelner SG, Coller BG, Boulos FC, Nogueira ML. Kallás EG, et al. Among authors: barral amp. N Engl J Med. 2024 Feb 1;390(5):397-408. doi: 10.1056/NEJMoa2301790. N Engl J Med. 2024. PMID: 38294972 Clinical Trial.
Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil.
Nogueira ML, Cintra MAT, Moreira JA, Patiño EG, Braga PE, Tenório JCV, de Oliveira Alves LB, Infante V, Silveira DHR, de Lacerda MVG, Pereira DB, da Fonseca AJ, Gurgel RQ, Coelho IC, Fontes CJF, Marques ETA, Romero GAS, Teixeira MM, Siqueira AM, Boaventura VS, Ramos F, Júnior EE, de Moraes JC, Whitehead SS, Esteves-Jaramillo A, Shekar T, Lee JJ, Macey J, Kelner SG, Coller BG, Boulos FC, Kallás EG; Phase 3 Butantan-DV Working Group. Nogueira ML, et al. Lancet Infect Dis. 2024 Nov;24(11):1234-1244. doi: 10.1016/S1473-3099(24)00376-1. Epub 2024 Aug 5. Lancet Infect Dis. 2024. PMID: 39116904 Clinical Trial.
Telomeric Chromatin and TERRA.
Barral A, Déjardin J. Barral A, et al. J Mol Biol. 2020 Jul 10;432(15):4244-4256. doi: 10.1016/j.jmb.2020.03.003. Epub 2020 Mar 7. J Mol Biol. 2020. PMID: 32151584 Review.
Chikungunya in a pediatric cohort: Asymptomatic infection, seroconversion, and chronicity rates.
de Jesus Pereira B, Brasil MQA, Silva JJ, Cristal JR, Carvalho IP, Miranda MCP, Paixão D, Khouri R, Cerqueira-Silva T, Boulos FC, Barral-Netto M, Kalas EG, Barral A, Bandeira A, Boaventura VS. de Jesus Pereira B, et al. Among authors: barral a. PLoS Negl Trop Dis. 2025 Jul 16;19(7):e0013254. doi: 10.1371/journal.pntd.0013254. eCollection 2025 Jul. PLoS Negl Trop Dis. 2025. PMID: 40668874 Free PMC article.
Decoding multidimensional biodiversity.
Barral A. Barral A. Nat Plants. 2019 May;5(5):450. doi: 10.1038/s41477-019-0431-y. Nat Plants. 2019. PMID: 31040444 No abstract available.
Leishmanial infection: analysis of its first steps. A review.
de Almeida MC, Vilhena V, Barral A, Barral-Netto M. de Almeida MC, et al. Among authors: barral a. Mem Inst Oswaldo Cruz. 2003 Oct;98(7):861-70. doi: 10.1590/s0074-02762003000700001. Epub 2004 Jan 7. Mem Inst Oswaldo Cruz. 2003. PMID: 14762510 Free article. Review.
311 results